Dr. François Marceau has been studying bradykinin receptors for over 30 years, their regulation, ligands and functions. Notably, as early as in the 1980s, the regulation of B1 receptor expression by cytokines and immunopathology was highlighted, with work replicated and expanded around the world. He has been part of an international committee on the nomenclature of bradykinin receptors, leading to a review article cited over 800 times, of which he is a co-author (Pharmacol Rev. 2005; 57: 27). More recently, two subjects have caught the attention of the laboratory, i.e. the creation of bifunctional biotechnological ligands for peptide hormone receptors, including those of bradykinin, and the angioedema states, presently the main clinical application of bradykinin. Dr. Marceau has been, and is, regularly invited as a speaker at specialized conferences.

CHUL
2705, boulevard Laurier
T-1-49
Québec, Québec
Canada G1V 4G2
+1 418-525-4444, extension 46155
+1 418-654-2765

Latest news

Data not available

184 entries « ‹ 1 of 19 › »

Charest-Morin X, Lodge R, Marceau F

Bifunctional fusion proteins containing the sequence of the bradykinin homologue maximakinin: activities at the rat bradykinin B2 receptor.

Journal Article

Can J Physiol Pharmacol, 96 (5), pp. 459-470, 2018, ISSN: 0008-4212.

Abstract | Links:

Marceau F

Editorial: Correspondence from Chirumbolo and Bjorklund.

Journal Article

Int Immunopharmacol, 55 , pp. A1, 2018, ISSN: 1567-5769.

| Links:

Bachelard H, Charest-Morin X, Marceau F

D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases.

Journal Article

Front Pharmacol, 9 , pp. 273, 2018.

Abstract | Links:

Marceau F, Bawolak MT, Fortin JP, Morissette G, Roy C, Bachelard H, Gera L, Charest-Morin X

Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity.

Journal Article

Peptides, 105 , pp. 37-50, 2018, ISSN: 0196-9781.

Abstract | Links:

Marceau F

Reprint of: Editorial: Correspondence from Chirumbolo and Bjorklund.

Journal Article

Int Immunopharmacol, 62 , pp. 334, 2018, ISSN: 1567-5769.

| Links:

Charest-Morin X, Hebert J, Rivard GE, Bonnefoy A, Wagner E, Marceau F

Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.

Journal Article

Front Immunol, 9 , pp. 2183, 2018, ISSN: 1664-3224.

Abstract | Links:

Charest-Morin X, Poubelle PE, Marceau F

Production and evaluation of parathyroid hormone receptor1 ligands with intrinsic or assembled peroxidase domains.

Journal Article

Sci Rep, 7 (1), pp. 13099, 2017, ISSN: 2045-2322.

Abstract | Links:

Charest-Morin X, Bachelard H, Jean M, Marceau F

Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rats.

Journal Article

PeerJ, 5 , pp. e2911, 2017.

Abstract | Links:

Rousseau LS, Pare G, Lachhab A, Naccache PH, Marceau F, Tessier P, Pelletier M, Fernandes M

S100A9 potentiates the activation of neutrophils by the etiological agent of gout, monosodium urate crystals.

Journal Article

J Leukoc Biol, 102 (3), pp. 805-813, 2017, ISSN: 0741-5400.

Abstract | Links:

Gera L, Charest-Morin X, Jean M, Bachelard H, Marceau F

Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B2 receptor: application to cytofluorometry and imaging.

Journal Article

BMC Res Notes, 9 (1), pp. 452, 2016.

Abstract | Links:

184 entries « ‹ 1 of 19 › »
Signaler des modifications

Active projects

  • Centre hospitalier universitaire de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Data provided by the Université Laval research projects registery